Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6883 USD | -20.11% |
|
-.--% | -20.11% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company shows low valuation levels, with an enterprise value at 0.79 times its sales.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-20.11% | 807M | - | ||
+14.19% | 5.11B | B- | ||
-33.68% | 3.43B | C+ | ||
-0.74% | 3.05B | C | ||
-24.38% | 2.59B | B- | ||
-9.94% | 2.2B | - | D+ | |
+39.98% | 1.86B | - | ||
+40.95% | 1.38B | - | ||
-14.41% | 1.37B | - | - | |
+45.87% | 1.36B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 1666 Stock
- TGRNF Stock
- Ratings Tong Ren Tang Technologies Co. Ltd.